These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30023681)

  • 21. Scalable and Chromatography-Free Synthesis of Efflux Pump Inhibitor Phenylalanine Arginine β-Naphthylamide for Its Validation in Wild-Type Bacterial Strains.
    Russo CM; Howey KG; O'Reilly MC
    ChemMedChem; 2023 Jul; 18(14):e202300128. PubMed ID: 37126222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro synergistic effect of amlodipine and imipenem on the expression of the AdeABC efflux pump in multidrug-resistant Acinetobacter baumannii.
    Hu C; Li Y; Zhao Z; Wei S; Zhao Z; Chen H; Wu P
    PLoS One; 2018; 13(6):e0198061. PubMed ID: 29856791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Impact of Efflux Pump Inhibitors on the Activity of Selected Non-Antibiotic Medicinal Products against Gram-Negative Bacteria.
    Laudy AE; Kulińska E; Tyski S
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28085074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Virtual screening and biological activity evaluation of novel efflux pump inhibitors targeting AdeB.
    Tuo Y; Tang Y; Yang R; Zhao X; Luo M; Zhou X; Wang Y
    Int J Biol Macromol; 2023 Oct; 250():126109. PubMed ID: 37544561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii.
    Peleg AY; Adams J; Paterson DL
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2065-9. PubMed ID: 17420217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mode of the Interaction of Efflux Inhibitor Phenylalanyl-arginyl-β-naphtylamide with Bacterial Cells.
    Sakalauskaitė S; Mikalayeva V; Sutkuvienė S; Daugelavičius R
    Biomedicines; 2024 Jun; 12(6):. PubMed ID: 38927531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of inhibitor binding hotspots in Acinetobacter baumannii β-ketoacyl acyl carrier protein synthase III using molecular dynamics simulation.
    Ha Y; Jang M; Lee S; Lee JY; Lee WC; Bae S; Kang J; Han M; Kim Y
    J Mol Graph Model; 2020 Nov; 100():107669. PubMed ID: 32659632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of iron on expression of efflux pump (adeABC) and quorum sensing (luxI, luxR) genes in clinical isolates of Acinetobacter baumannii.
    Modarresi F; Azizi O; Shakibaie MR; Motamedifar M; Valibeigi B; Mansouri S
    APMIS; 2015 Nov; 123(11):959-68. PubMed ID: 26350174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of highly ciprofloxacin resistance acinetobacter baumannii isolated from patients with burn wound infections in presence and absence of efflux pump inhibitor.
    Maleki MH; Jalilian FA; Khayat H; Mohammadi M; Pourahmad F; Asadollahi K; Pakzad I; Sadeghifard N; Soroush S; Emaneini M; Taherikalani M
    Maedica (Bucur); 2014 Jun; 9(2):162-7. PubMed ID: 25705272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unidirectional peristaltic movement in multisite drug binding pockets of AcrB from molecular dynamics simulations.
    Feng Z; Hou T; Li Y
    Mol Biosyst; 2012 Oct; 8(10):2699-709. PubMed ID: 22825052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AdeR-AdeS mutations & overexpression of the AdeABC efflux system in ciprofloxacin-resistant
    Lari AR; Ardebili A; Hashemi A
    Indian J Med Res; 2018 Apr; 147(4):413-421. PubMed ID: 29998878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of the efflux inhibitors 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-beta-naphthylamide on antimicrobial susceptibility and virulence factor production in Vibrio cholerae.
    Bina XR; Philippart JA; Bina JE
    J Antimicrob Chemother; 2009 Jan; 63(1):103-8. PubMed ID: 19010827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phenylalanine-arginine beta-naphthylamide sensitive multidrug efflux pump involved in intrinsic and acquired resistance of Campylobacter to macrolides.
    Mamelli L; Amoros JP; Pagès JM; Bolla JM
    Int J Antimicrob Agents; 2003 Sep; 22(3):237-41. PubMed ID: 13678827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of AdeABC efflux pump genes in tetracycline-resistant Acinetobacter baumannii isolates from burn and ventilator-associated pneumonia patients.
    Beheshti M; Talebi M; Ardebili A; Bahador A; Lari AR
    J Pharm Bioallied Sci; 2014 Oct; 6(4):229-32. PubMed ID: 25400404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An efflux pump (MexAB-OprM) of Pseudomonas aeruginosa is associated with antibacterial activity of Epigallocatechin-3-gallate (EGCG).
    Kanagaratnam R; Sheikh R; Alharbi F; Kwon DH
    Phytomedicine; 2017 Dec; 36():194-200. PubMed ID: 29157815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution of adeB and NDM-1 genes in multidrug resistant Acinetobacter baumannii isolated from infected wound of patients admitted in a tertiary care hospital in Bangladesh.
    Hasan MJ; Shamsuzzaman SM
    Malays J Pathol; 2017 Dec; 39(3):277-283. PubMed ID: 29279590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The AcrB efflux pump: conformational cycling and peristalsis lead to multidrug resistance.
    Seeger MA; Diederichs K; Eicher T; Brandstätter L; Schiefner A; Verrey F; Pos KM
    Curr Drug Targets; 2008 Sep; 9(9):729-49. PubMed ID: 18781920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus-Acinetobacter baumannii complex.
    Ruzin A; Keeney D; Bradford PA
    J Antimicrob Chemother; 2007 May; 59(5):1001-4. PubMed ID: 17363424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of adeB gene expression levels under conditions of induced resistance by different drugs
    Zhu W; Wang H; Zhang JP
    Exp Ther Med; 2017 May; 13(5):2177-2182. PubMed ID: 28565825
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quercetin inhibits carbapenemase and efflux pump activities among carbapenem-resistant Gram-negative bacteria.
    Pal A; Tripathi A
    APMIS; 2020 Mar; 128(3):251-259. PubMed ID: 31755586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.